For the quarter ending 2026-03-31, RNXT has $13,964K in assets. $2,699K in debts. $12,362K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 12,362 | 7,024 | 10,044 | 12,314 |
| Accounts receivable | 280 | 139 | 169 | 363 |
| Prepaid expenses | 501 | 324 | 350 | 430 |
| Inventory | 379 | 189 | 272 | - |
| Other current assets | 198 | 217 | 145 | 288 |
| Total current assets | 13,720 | 7,893 | 10,980 | 13,395 |
| Operating lease right-of-use asset | 167 | 190 | 213 | 235 |
| Property and equipment, net | 77 | 12 | 13 | 13 |
| Total assets | 13,964 | 8,095 | 11,206 | 13,643 |
| Accounts payable | 1,119 | 799 | 869 | 671 |
| Accrued expenses and other current liabilities | 801 | 1,163 | 1,015 | 885 |
| Total current liabilities | 1,920 | 1,962 | 1,884 | 1,556 |
| Common stock warrant liability | 701 | 604 | 1,110 | 1,285 |
| Operating lease liability, net of current portion | 78 | 107 | 134 | 161 |
| Total liabilities | 2,699 | 2,673 | 3,128 | 3,002 |
| Common stock, 0.0001 par value, 250,000,000 shares authorized at march 31, 2026, and december 31, 2025 45,052,706 and 36,613,916 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 5 | 4 | 4 | 4 |
| Additional paid-in capital | 76,168 | 66,805 | 66,520 | 66,171 |
| Accumulated deficit | -64,908 | -61,387 | -58,446 | -55,534 |
| Total stockholders' equity | 11,265 | 5,422 | 8,078 | 10,641 |
| Total liabilities and stockholders' equity | 13,964 | 8,095 | 11,206 | 13,643 |
RenovoRx, Inc. (RNXT)
RenovoRx, Inc. (RNXT)